Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
docusate sodium
- Development stage
- Phase 4
- Modality
- Small Molecules
- Administration
- Oral, Rectal
01
Overview
Docusate sodium is a stool softener used to treat occasional constipation by increasing the amount of water the stool absorbs in the gut, making it softer and easier to pass. It acts as an anionic surfactant, reducing surface tension and allowing water and lipids to penetrate the stool, thus facilitating natural defecation. The onset of action is typically within 1 to 3 days when taken orally. Docusate's effectiveness in treating constipation is debated, with some studies suggesting it is no more effective than a placebo.
- Brand names
- ColaceColace ClearDocu SoftDoculaseDocusate Mini
- Other names
- dioctyl sulfosuccinate
Beyond the preview
Go deeper on docusate sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on docusate sodium.